Platelet studies in autism spectrum disorder patients and first-degree relatives

Molecular Autism

Volumn 6, Issue 1, 2015, Pages

  Bijl, Nora ^a,b   Thys, Chantal ^a   Wittevrongel, Christine ^a   De La Marche, Wouter ^b   Devriendt, Koenraad ^b   Peeters, Hilde ^b   Van Geet, Chris ^a,b   Freson, Kathleen ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

ATP secretion; Autism; Dense granules; Platelet activation; Platelets; Serotonin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENALIN; COLLAGEN; SEROTONIN;

ADULT; ARTICLE; AUTISM; CELL GRANULE; CELL SIZE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATHER; FEMALE; FIRST DEGREE RELATIVE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOTHER; PRIORITY JOURNAL; PROTEIN SECRETION; SCORING SYSTEM; SEROTONIN BLOOD LEVEL; SIBLING; SOCIAL BEHAVIOR; SOCIAL RESPONSIVENESS SCORE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION;

EID: 84945126616     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/s13229-015-0051-y     Document Type: Article

References (59)

1. Developmental Disabilities Monitoring Network. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ. 2014;63:1-21.
2. Constantino JN, Todorov A, Hilton C, Law P, Zhang Y, Molloy E, et al. Autism recurrence in half siblings: strong support for genetic mechanisms of transmission in ASD. Mol Psychiatry. 2013;18:137-8.
3. Caglayan AO. Genetic causes of syndromic and non-syndromic autism. Dev Med Child Neurol. 2010;52:130-8.
4. Persico AM, Napolioni V. Autism genetics. Behav Brain Res. 2013;251:95-112.
5. Ronemus M, Iossifov I, Levy D, Wigler M. The role of de novo mutations in the genetics of autism spectrum disorders. Nat Rev Genet. 2014;15:133-41.
6. Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014;94:677-94.
7. Krumm N, O'Roak BJ, Shendure J, Eichler EE. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci. 2014;37:95-105.
8. Ben-David E, Shifman S. Networks of neuronal genes affected by common and rare variants in autism spectrum disorders. PLoS Genet. 2012;8:e1002556.
9. Gai X, Xie HM, Perin JC, Takahashi N, Murphy K, Wenocur AS, et al. Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry. 2012;17:402-11.
10. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron. 2011;70:898-907.
11. Jeste SS, Geschwind DH. Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat Rev Neurol. 2014;10:74-81.
12. Shinoda Y, Sadakata T, Furuichi T. Animal models of autism spectrum disorder (ASD): a synaptic-level approach to autistic-like behavior in mice. Exp Anim. 2013;62:71-8.
13. Stewart AM, Nguyen M, Wong K, Poudel MK, Kalueff AV. Developing zebrafish models of autism spectrum disorder (ASD). Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:27-36.
14. Goubau C, Buyse GM, Van Geet C, Freson K. The contribution of platelet studies to the understanding of disease mechanisms in complex and monogenetic neurological disorders. Dev Med Child Neurol. 2014;56:724-31.
15. Ehrlich D, Humpel C. Platelets in psychiatric disorders. World J psychiatry. 2012;2:91-4.
16. Goubau C, Devriendt K, Van der Aa N, Crepel A, Wieczorek D, Kleefstra T, et al. Platelet defects in congenital variant of Rett syndrome patients with FOXG1 mutations or reduced expression due to a position effect at 14q12. Eur J Hum Genet. 2013;21:1349-55.
17. Goubau C, Jaeken J, Levtchenko EN, Thys C, Di Michele M, Martens GA, et al. Homozygosity for aquaporin 7 G264V in three unrelated children with hyperglyceroluria and a mild platelet secretion defect. Genet Med. 2013;15:55-63.
18. Di Michele M, Goubau C, Waelkens E, Thys C, De Vos R, Overbergh L, et al. Functional studies and proteomics in platelets and fibroblasts reveal a lysosomal defect with increased cathepsin-dependent apoptosis in ATP1A3 defective alternating hemiplegia of childhood. J Proteomics. 2013;86:53-69.
19. Freson K, Izzi B, Labarque V, Van Helvoirt M, Thys C, Wittevrongel C, et al. GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets. J Clin Endocrinol Metab. 2008;93:4851-9.
20. Boullin DJ, Coleman M, O'Brien RA. Abnormalities in platelet 5-hydroxytryptamine efflux in patients with infantile autism. Nature. 1970;226:371-2.
21. Pletscher A. Platelets as models for monoaminergic neurons. Essays Neurochem Neuropharmacol. 1978;3:49-101.
22. Lesch KP, Wolozin BL, Murphy DL, Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem. 1993;60:2319-22.
23. Goubau C, Buyse GM, Di Michele M, Van Geet C, Freson K. Regulated granule trafficking in platelets and neurons: a common molecular machinery. Eur J Paediatr Neurol. 2013;17:117-25.
24. Reed GL, Fitzgerald ML, Polgár J. Molecular mechanisms of platelet exocytosis: insights into the "secrete" life of thrombocytes. Blood. 2000;96:3334-42.
25. Asor E, Ben-Shachar D. Platelets: a possible glance into brain biological processes in schizophrenia. World J psychiatry. 2012;2:124-33.
26. Danese E, Montagnana M, Lippi G. Platelets and migraine. Thromb Res. 2014;134:17-22.
27. Veitinger M, Varga B, Guterres SB, Zellner M. Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? Acta Neuropathol Commun. 2014;2:65.
28. Pagan C, Delorme R, Callebert J, Goubran-Botros H, Amsellem F, Drouot X, et al. The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Transl Psychiatry. 2014; doi: 10.1038/tp.2014.120
29. Cross S, Kim SJ, Weiss LA, Delahanty RJ, Sutcliffe JS, Leventhal BL, et al. Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology. 2008;33:353-60.
30. Cook Jr EH, Leventhal BL, Freedman DX. Free serotonin in plasma: autistic children and their first-degree relatives. Biol Psychiatry. 1988;24:488-91.
31. Piven J, Tsai GC, Nehme E, Coyle JT, Chase GA, Folstein SE. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord. 1991;21:51-9.
32. Gabriele S, Sacco R, Persico AM. Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24:919-29.
33. Janušonis S. Serotonin dynamics in and around the central nervous system: is autism solvable without fundamental insights? Int J Dev Neurosci. 2014;39:9-15.
34. Brand T, Anderson GM. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem. 2011;57:1376-86.
35. Castermans D, Volders K, Crepel A, Backx L, De Vos R, Freson K, et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet. 2010;19:1368-78.
36. Volders K, Nuytens K, Creemers JWM. The autism candidate gene Neurobeachin encodes a scaffolding protein implicated in membrane trafficking and signaling. Curr Mol Med. 2011;11:204-17.
37. Nuytens K, Gantois I, Stijnen P, Iscru E, Laeremans A, Serneels L, et al. Haploinsufficiency of the autism candidate gene Neurobeachin induces autism-like behaviors and affects cellular and molecular processes of synaptic plasticity in mice. Neurobiol Dis. 2013;51:144-51.
38. Nuytens K, Tuand K, Di Michele M, Boonen K, Waelkens E, Freson K, et al. Platelets of mice heterozygous for neurobeachin, a candidate gene for autism spectrum disorder, display protein changes related to aberrant protein kinase A activity. Mol Autism. 2013;4:43.
39. De la Marche W, Noens I, Kuppens S, Spilt JL, Boets B, Steyaert J. Measuring quantitative autism traits in families: informant effect or intergenerational transmission? Eur Child Adolesc Psychiatry. 2014;24(4):385-95.
40. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Publishing Inc; 2000.
41. Skuse D, Warrington R, Bishop D, Chowdhury U, Lau J, Mandy W, et al. The developmental, dimensional and diagnostic interview (3di): a novel computerized assessment for autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2004;43:548-58.
42. Constantino JN, Gruber CP. Social Responsiveness Scale (SRS). Los Angelos: Western Psychological Services; 2005.
43. Di Michele M, Thys C, Waelkens E, Overbergh L, D'Hertog W, Mathieu C, et al. An integrated proteomics and genomics analysis to unravel a heterogeneous platelet secretion defect. J Proteomics. 2011;74:902-13.
44. Rabe-Hesketh S, Skrondal A, Gjessing HK. Biometrical modeling of twin and family data using standard mixed model software. Biometrics. 2008;64:280-8.
45. Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, Pistis G, et al. New gene functions in megakaryopoiesis and platelet formation. Nature. 2011;480:201-8.
46. Bessman JD, Williams LJ, Gilmer PR. Mean platelet volume. The inverse relation of platelet size and count in normal subjects, and an artifact of other particles. Am J Clin Pathol. 1981;76:289-93.
47. Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets. 2001;12:261-73.
48. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood. 2014;123:2759-67.
49. Ambrosio AL, Boyle JA, Di Pietro SM. Mechanism of platelet dense granule biogenesis: study of cargo transport and function of Rab32 and Rab38 in a model system. Blood. 2012;120:4072-81.
50. Chen L, Kostadima M, Martens JH, Canu G, Garcia SP, Turro E, et al. Transcriptional diversity during lineage commitment of human blood progenitors. Science. 2014;345:1251033.
51. Westbury SK, Turro E, Greene D, Lentaigne C, Kelly AM, Bariana TK, et al. BRIDGE-BPD Consortium. Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders. Genome Med. 2015;7:36.
52. Freson K, Wijgaerts A, van Geet C. Update on the causes of platelet disorders and functional consequences. Int J Lab Hematol. 2014;36:313-25.
53. Factor SA, Ortof E, Dentinger MP, Mankes R, Barron KD. Platelet morphology in Parkinson's disease: an electron microscopic study. J Neurol Sci. 1994;122:84-9.
54. Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, et al. Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients. J Proteomics. 2012;75:2080-92.
55. Williams MS. Platelets and depression in cardiovascular disease: a brief review of the current literature. World J psychiatry. 2012;2:114-23.
56. Tiedt R, Coers J, Ziegler S, Wiestner A, Hao-Shen H, Bornmann C, et al. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Blood. 2009;113:1768-77.
57. Geller E, Yuwiler A, Freeman BJ, Ritvo E. Platelet size, number, and serotonin content in blood of autistic, childhood schizophrenic, and normal children. J Autism Dev Disord. 1988;18:119-26.
58. Marazziti D, Muratori F, Cesari A, Masala I, Baroni S, Giannaccini G, et al. Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry. 2000;33:165-8.
59. Mazalouskas M, Jessen T, Varney S, Sutcliffe JS, Veenstra-VanderWeele J, Cook EH, et al. Integrin β3 haploinsufficiency modulates serotonin transport and antidepressant-sensitive behavior in mice. Neuropsychopharmacology. 2015; doi: 10.1038/npp.2015.51